期刊文献+

人口腔鳞癌细胞系对淋巴靶向葫芦素BE聚乳酸纳米微粒的敏感性研究 被引量:12

Effects of Cucurbitacin BE Polylactic Acid Nanoparticles on Human Oral Squamous Carcinoma Cell Lines
下载PDF
导出
摘要 目的 :探讨人口腔鳞癌细胞系 (Tca8113和BcaCD885 )对颈淋巴结靶向性葫芦素BE聚乳酸纳米微粒 (CuBE_PLA_NP)的敏感性。方法 :用四唑盐显色法 (MTT法 )检测用不同剂量的CuBE_PLA_NP和CuBE在 1~ 8d内 8个时间点对Tca8113和BcaCD885的抗癌活性 ,计算出 2种药物在 8个时间点对 2种癌细胞的抑癌率和药物的半数抑癌率浓度。结果 :CuBE_PLA_NP和CuBE对Tca8113和BcaCD885均有强的杀伤作用 ,其杀伤效应均呈时间依赖性和剂量依赖性。结论 :经改型后的淋巴靶向CuBE_PLA_NP没有降低CuBE成份的抗癌活性 ,同时 ,由于CuBE_PLA_NP具有淋巴靶向性 ,更有利于杀灭口腔癌颈淋巴结转移灶内的癌细胞。 Objective:The aim of this study was to study cytotoxic effects of cucurbitacin BE polylactic acid nanoparticles (CuBE_PLA_NP) on human oral squamous carcinoma cell lines Tca8113 (tongue carcinoma) and BcaCD885 (buccal carcinoma).Methods:The chemosensitivity of Tca8113 and BcaCD885 to CuBE_PLA_NP and CuBE was tested using MTT assay, the inhibitory rate and 50% inhibition concentrations values (IC_50) of these two drugs against these two cancer cell lines were evaluated in 1,2,3,4,5,6,7 and 8 days with different concentrations.Results:Both CuBE_PLA_NP and CuBE showed very high anti_cancer effects on Tca8113 and BcaCD855, and the anticancer efficacy of these two drugs was dose_ and time_dependent.Conclusion:The effects of CuBE_PLA_NP on lymph nodes of metastatic cancer cells were higher than that of CuBE.\;
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2002年第4期293-295,共3页 West China Journal of Stomatology
基金 卫生部科学基金 (编号 98_1_2 2 1) 重庆医科大学附属第一医院科研启动基金 (编号 2 0 0 2 0 0 7)
关键词 敏感性研究 葫芦素BE 聚乳酸 钠米微粒 口腔癌 颈淋巴结转移 靶向化疗 四唑盐显色法 治疗 cucurbitacinBE polylactic acid nanoparticles oral carcinoma\ \ cervical lymph node metastasis\ \ targeted chemotherapy\ \ MTT assay\
  • 相关文献

参考文献7

  • 1杨凯,温玉明,李超英,王昌美,李龙江.口腔鳞癌细胞系对葫芦素BE的敏感性研究[J].临床口腔医学杂志,2001,17(1):17-18. 被引量:11
  • 2杨凯,温玉明,李龙江,王昌美,侯世祥,李超英.颈淋巴结靶向葫芦素BE聚乳酸纳米微粒冻干针剂的研制[J].华西口腔医学杂志,2001,19(6):347-350. 被引量:23
  • 3Carmicheal J, Mitchell JB, DeGraff WG, et al. Chemosensifivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer, 1988, 57(6) :540 - 547
  • 4Ohe Y, Nakagawa K, Fujiwara Y, et al. In vitro evaluation of the new anfitumor agents KT6149, MX-Z, SM5887, menogaril,and liblomycin using cisplatin-or-adriamycin-resistant human cancer cell lines. Cancer Res, 1989, 49(10) :4098 - 4102
  • 5Hofs HP, Wagener DJ, Bakker V. Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with anfitumor agents. Anticancer Drugs, 1994, 5(1):35 -42
  • 6Nozue M, Hishida M, Todoroki T, et al. Selection of three of 24 anticancer agents in poody differentiated gastric cancer cell lines evaluated by the AVC delta IC50 ratio. Anticancer Drugs, 1995,6(2) :291 - 302
  • 7刘颖菊,刘文清.葫芦素的药理与临床应用[J].中草药,1992,23(11):605-608. 被引量:27

二级参考文献44

共引文献50

同被引文献117

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部